NCT00345345 2022-05-03Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte LeukemiaNational Institutes of Health Clinical Center (CC)Phase 2 Completed29 enrolled 17 charts
NCT00040846 2020-01-29Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesFred Hutchinson Cancer CenterPhase 2 Completed60 enrolled 10 charts
NCT00278213 2018-05-11Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaGerman CLL Study GroupPhase 2 Completed17 enrolled